Sekisui Diagnostics Ammonia L3K Assay; Catalog Number: 293-80-91 and 293-10 For the IN…
Recall Z-1078-2017, part of FDA recall event 75818. See Sekisui Diagnostics P.E.I.'s company page.
Sekisui Diagnostics P.E.I. Inc. started this Class II device recall on Nov 29, 2016 (voluntary: firm initiated); FDA lists it as terminated, terminated Jul 6, 2017.
- Classification: Class II
- Started: Nov 29, 2016
- Status: Terminated
Certain lots are showing an atypical decrease in optical density (OD) over time, which may result in an impact to performance at the high end of the linear range.
- Product
- Sekisui Diagnostics Ammonia L3K Assay; Catalog Number: 293-80-91 and 293-10 For the IN VITRO quantitative measurement of ammonia concentration in plasma
- Quantity
- 774 Liters bulk and 565 kits
- Lots and codes
- Catalog Number: 293-80-91; Lot Numbers: 48737, 48962, 49087, 49220, 49258 and Catalog Numbers: 293-10; Lot Numbers: 48967, 49330, 49331, 49515
- Distribution
- Worldwide Distribution - US including DE, KS, FL, TX, CA, MI, TN, MA, ID, NJ, RI, IL and Internationally to Austria, Mexico, Canada, India, South Korea, China, Spain, South Korea, and Sri Lanka
- Recalling firm
- Sekisui Diagnostics P.E.I. Inc., Charlottetown, N/A, Canada
- How the firm notified
- Letter
- FDA classified
- Jan 23, 2017
Newest first, one product per recall event; search them all
- Sekure Chemistry Sekisui Diagnostics Acetaminophen L3K Assay, In-vitro Diagnostic Catalog Number: 506-10: R1: 1 x…Z-1171-2016 · Class II · Jan 22, 2016 · Terminated
FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports